ArticleJournal of biomedical optics2026
Development of solid-state fluorescence lifetime standards for clinical applications using dyed epoxy resins.
Article in Journal of biomedical optics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Fluorescence lifetime imaging (FLIm) offers label-free contrast based on intrinsic tissue properties, making it a promising tool for clinical diagnostics and intraoperative guidance. However, the lack of robust, reproducible standards for system validation limits cross-platform comparability, impedes quality assurance, and hinders clinical translation. Aim: We aim to develop and characterize a set of stable solid-state fluorescence lifetime (FLT) standards using dyed epoxy resins, with the goal of enabling reliable calibration, benchmarking, and validation of FLIm systems in both research and clinical environments. Approach: A series of solid standards incorporating different dyes were fabricated to span a range of lifetimes from sub-nanosecond to over 3.5 ns. These materials were evaluated for FLT, emission intensity, photostability under UV exposure, and fabrication repeatability. The influence of dye concentration and microstructural uniformity was assessed using a confocal microscope. The standards were also applied to validate a chip-on-tip FLIm micro-camera designed for endoscopic imaging. Results: The dyed epoxy standards demonstrated consistent and reproducible lifetimes, good photostability, and scalable fabrication. Confocal imaging revealed some microstructural heterogeneity, whereas bulk measurements remained robust. The standards enabled effective validation of the FLIm micro-camera, including spatial and temporal resolution assessment, and highlighted platform-dependent biases in lifetime estimation. Conclusions: Dyed epoxy materials show strong potential as practical, scalable tools for FLIm system calibration and quality assurance. These standards may support cross-platform validation and benchmarking of emerging FLIm technologies and could contribute to the development of future regulatory frameworks for clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.